| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ASH, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, and SVH 2021 guidelines for management of venous thromboembolism in Latin America
|
Neumann, Ignacio
|
|
|
5 |
15 |
p. 3032-3046
|
artikel
|
| 2 |
Bleeding diathesis in mice lacking JAK2 in platelets
|
Eaton, Nathan
|
|
|
5 |
15 |
p. 2969-2981
|
artikel
|
| 3 |
Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy
|
Miller, Peter G.
|
|
|
5 |
15 |
p. 2982-2986
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
5 |
15 |
p. i
|
artikel
|
| 5 |
Effective anti-BCMA retreatment in multiple myeloma
|
Gazeau, Nicolas
|
|
|
5 |
15 |
p. 3016-3020
|
artikel
|
| 6 |
FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma
|
Bigley, Austin B.
|
|
|
5 |
15 |
p. 3021-3031
|
artikel
|
| 7 |
Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS
|
Baronciani, Luciano
|
|
|
5 |
15 |
p. 2987-3001
|
artikel
|
| 8 |
Identification of the transcription factor MAZ as a regulator of erythropoiesis
|
Deen, Darya
|
|
|
5 |
15 |
p. 3002-3015
|
artikel
|
| 9 |
Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study
|
Brink, Mirian
|
|
|
5 |
15 |
p. 2958-2964
|
artikel
|
| 10 |
Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP
|
Bernard, Sophie
|
|
|
5 |
15 |
p. 2965-2968
|
artikel
|
| 11 |
Methodology for adaptation of the ASH Guidelines for Management of Venous Thromboembolism for the Latin American context
|
Neumann, Ignacio
|
|
|
5 |
15 |
p. 3047-3052
|
artikel
|
| 12 |
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment
|
Nowicka, Malgorzata
|
|
|
5 |
15 |
p. 2945-2957
|
artikel
|
| 13 |
Single-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma
|
Strefford, Jonathan C.
|
|
|
5 |
15 |
p. 2935-2944
|
artikel
|
Tijdschrift beschrijving